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Abstract: Ultrasound imaging (US) of the prostate has a low specificity to 
distinguish tumors from the surrounding tissues. This limitation leads to 
systematic biopsies. Fluorescent diffuse optical imaging may represent an 
innovative approach to guide biopsies to tumors marked with high 
specificity contrast agents and therefore enable an early detection of prostate 
cancer. This article describes a time-resolved optical system embedded in a 
transrectal US probe, as well as the fluorescence reconstruction method and 
its performance. Optical measurements were performed using a pulsed laser, 
optical fibers and a time-resolved detection system. A novel fast 
reconstruction method was derived and used to locate a 45 µL ICG 
fluorescent inclusion at a concentration of 10 µM, in a liquid prostate 
phantom. Very high location accuracy (0.15 cm) was achieved after 
reconstruction, for different positions of the inclusion, in the three directions 
of space. The repeatability, tested with ten sequential measurements, was of 
the same order of magnitude. Influence of the input parameters (optical 
properties and lifetime) is presented. These results confirm the feasibility of 
using optical imaging for prostate guided biopsies. 
©2010 Optical Society of America 
OCIS codes: (170.5280) Photon migration; (170.3660) Light propagation in tissues; (170.7050) 
Turbid media; (170.6920) Time-resolved imaging; (300.2530) Fluorescence, laser-induced; 
(170.3880) Medical and biological imaging. 
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1. Introduction 
Diffuse optical tomography is an emerging and promising technique for biological tissue 
screening [1]. The main advantage of this optical method compared to others in molecular 
imaging is that it remains noninvasive and non-ionizing. 
These assets are particularly beneficial for prostate imaging applications. Indeed the 
current diagnosis is based on prostate specific antigen (PSA) dosage and digital rectal 
examination [2,3]. If one of these tests is abnormal, an ultrasound (US) guided biopsy may be 
performed. Even if it is considered as the gold standard for now, this technique presents 
several drawbacks. In particular, the lack of sensitivity and specificity of sonography alone 
impacts significantly the localization of tumor targets. Biopsies are thus performed randomly 
yielding a global false negative rate of 30-40% [4,5], and implying repeated biopsies. In 
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higher risk of false negative diagnosis [7,8]. 
To improve the specificity on prostate imaging by guiding biopsies to tumors, it has been 
proposed to combine near infrared diffuse optical tomography with ultrasound [9]. The 
assumption is that tumors are more vascularised than the surrounding tissue. This technique 
was successfully demonstrated in vivo on canine prostate to discriminate tumor nodules and 
normal tissue [10]. The authors used a sagittal fiber array coupled to a continuous wave 
source. 
Here, we propose to use fluorescence optical tomography to further increase the contrast 
between tumors and healthy tissue. We also chose to perform time-resolved acquisitions to 
accommodate the prostate reflectance geometry. Fluorescent time-resolved experiments have 
been performed in reflectance mode on other organs such as the brain [11], or on tissue-like 
phantoms [12]. Gao et al. [13] presented a full tomographic device in transmittance mode on a 
small animal sized phantom. 
Optical measurements on prostate are challenging because of the high absorption 
coefficient (µa = 0.3-0.4 cm
1 at 786 nm [14]) and the small contact surface between the probe 
and the tissue. Our group had previously presented a prostate dedicated device combining 
fluorescence tomography and ultrasound technologies [15]. Based on this device, we 
developed a novel faster detection system based on time-correlated single photon counting 
(TCSPC). We also improved our reconstruction algorithm and characterized the device 
resolution. 
In Section 2, our time-resolved experimental setup is described. We also present the 
forward model we employed within the diffusion approximation to obtain the Green’s 
functions. The derivation of our original method is explained subsequently and preprocessing 
of the experimental data is detailed. In Section 3, we show the ability of the system to localize 
a single inclusion in a prostate mimicking phantom. 
2. Materials and methods 
2.1. Experimental setup 
The main parts of the experimental system (Fig. 1) are described in detail in reference [15]. 
Here a similar laser was operated but the detection part has been changed to speed up data 
acquisition [16]. The gated CDD camera has been replaced by four photomultiplicators 
(PMTs) coupled to a TCSPC system. 
The laser source was a pulsed Ti:sapphire laser (Chameleon, Coherent, Santa Clara, USA) 
tuned at 775 nm, at 80 MHz repetition rate. The light was filtered by a band pass excitation 
filter (FB770, Thorlabs) then was injected to an input excitation fiber mounted on a 
displacement plate in order to rout sequentially the light through a six fiber bundle and the six 
sources on the probe. It allowed the medium to be probed by light from six different locations. 
The light reemitted by the probed medium was then collected by four plastic detection fibers. 
Each detection fiber was coupled to its own photomultiplier (PMC-100-20, Becker&Hickl, 
Germany). A set of emission filters (Notch NF01-785U-25, Razoredge LP02-785RS-25, 
Semrock and RG850, Itos) was placed in front of each PM head to select fluorescent light. A 
four-channel TCSPC module (SPC-134, Becker&Hickl, Germany) analyzed the signals from 
the four PMTs. The synchronization signal was derived from the main beam after the laser 
exit and was measured with a photodiode. An adequate cable length ensured the correct 
synchronization delay regarding our system. 
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Fig. 1. Illustration of the experimental setup. 
Figure 2 shows the setup of the fibers at the outer end of the US probe and its orientation. 
The fibers are housed between the plastic shell of the probe and the transducer core. 
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Fig. 2. (a) Optical fibers configuration at the end of the probe (b) Position of the probe and axis 
representation (the basis is clockwise). 
We designed a liquid phantom mimicking the prostate optical properties. It was made of 
Intralipid at a concentration of 1% as the scattering medium and black India ink (Dalbe, 
France) as the absorber. The relative concentrations were adjusted to reach levels of  a   = 0.3 
cm
1, 
'
s   = 12 cm
1 at 775 nm which are typical prostate optical parameters [14]. The optical 
properties were controlled by a standard TCSPC techniques [17,18]. A cylindrical plastic tank 
(diameter 11 cm; height 8 cm) was filled with the phantom solution. The probe was immersed 
1 cm below the surface to simulate the pressure of the probe on the rectum wall inside the 
prostate. 
We simulated a tumor targeted by a biomarker by using a 45 µL volume of Indocyanine 
Green (ICG) encapsulated in nanodroplets [19] (peak excitation and emission wavelength at 
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4.4 mm and length: 5 mm). The glass tube was positioned perpendicularly to the sources-
detectors line, along the x axis, its outer extremity hold on the x<0 side. The lifetime of the 
fluorophore (τ = 0.55ns) was also measured by standard time-resolved techniques. 
2.2. Forward model 
Diffusion equation 
Light propagation in the diffusive medium is described by the diffusion equation [20]: 
  
(,) 1
() (,) () (,) ( ,)
s
sa s s
Gr t
Dr G rt rG rt r rt
ct


    

       
   (1) 
where  c is the light velocity,  () Dr

 is the diffusion coefficient,  () a r 

is the absorption 
coefficient,  (,) rt 

 is the Dirac distribution and  (,) s Gr t

is the photon density resulting from 
the Dirac source excitation (Green’s function). 
For media with arbitrary boundaries or arbitrary optical properties, numerical calculation 
must be performed to obtain Gs. However, solving directly Eq. (1) implies huge memory and 
computation requirements since one must solve Nt times a steady state diffusion equation (Nt 
being the number of time steps of the calculations). In order to reduce memory and 
computation time, we used the moments of Gs. Here, the n
th order moment of a function f(t) is 
defined as: 
  ()
(n) n f fttd t


     (2) 
As shown in [21], moments of Gs are easily reachable since they follow the equation: 
  
(1 )
() () (, )
n
nn s
sa s s
nG
DG G r r n
c


     
  
   (3) 
where  (,) () rn r   

for n = 0, and  (,) rn 

 = 0 otherwise, and 
() n
s G  = 0 for n<0. Equation (3) 
shows that 
() n
s G  is the solution of steady state diffusion equation with a source term including 
(1 ) n
s G
 . After meshing our volume, the Green’s function list
(0)
s G ,…,
() n
s G can therefore be 
numerically determined by inverting n + 1 times an equation LX = S where 
operator  . a LD      
 
 is an operator whose expression can be found by using the 
finite element method (FEM) or the finite volume method (FVM). Partial current boundary 
conditions were applied to the probe boundary and the medium’s edges. Finally, we obtain a 
table with the Green functions values on each point of the mesh. 
Excitation and emission measurements 
Two types of time-domain measurements were performed to optically probe a medium of 
interest: excitation measurements, i.e. measurements at the wavelength of the laser source, and 
fluorescence or emission measurements, i.e. measurements at a wavelength above the laser 
source obtained by using a filter. Furthermore, multiple sources (indexed by s) and detectors 
(indexed by d) were used to provide a set of measurements allowing tomographic 
reconstruction. In addition, optical properties were assumed to be the same at the excitation 
and emission wavelength. 
Excitation measurements (named 
x
sd U ) are described by three physical processes: the time 
shape of the source (the laser source and propagation inside the source fiber), the propagation 
inside the diffusive medium (named  ˆ x
sd U as the model-predicted data) and the detection time 
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neglect it here, considering only high signal to noise measurements. As these processes are 
independent, emission measurements are expressed as below, 
 
ˆ () () ()
() ( ,)
xx
sd sd sd
sd s d
Ut I R FtUt
IRF t G r t


  (4) 
where IRFsd is the instrument response function (IRF, convolution of the time response of the 
source and detection parts) and * stands for the time convolution operator.  ˆ ()
x
sd Ut  would be 
the excitation response of an ideal instrument, that is to say for a Dirac instrument response 
function. 
Emission measurements may be written as the convolution product of five processes: the 
source emission, the propagation from the source to a fluorescence site, the fluorescence 
exponential decay, the propagation at the fluorescence wavelength from the fluorescence site 
to the detection point and the detection. As these processes are independent, emission 
measurements follow this equation: 
 
ˆ () () ()
() (,) (,) (,)
mm
sd sd sd
sd s d
Ut I R FtUt
IRF t G r t F r t G r t dr



   
 
    (5) 
where  (,) F rt

 is the fluorescence time-response at location r

,  (,) d Gr t

is the Green’s function 
for a Dirac located at the detector position. IRFsd is the same function as in Eq. (4) as we 
assumed that detection responses are equivalent at the excitation and emission wavelength. 
ˆ ()
m
sd Ut would be the emission response of an ideal instrument. Here, we suppose that only one 
kind of fluorophore with lifetime τ is present, therefore F is modeled as 
(0) (,) () . e x p ( /) / Frt F r t  

 where 
(0) F  is related to the concentration of fluorophore at 
position  r

 and to the cross section of the fluorophore. We are interested in reconstructing the 
(0) F  map from the optical measurements. 
2.3. Reconstruction method 
We derived a method based on the first two “moments” of the measured fluorescent signal 
(intensity and mean time), with an explicit account of the excitation measurement, which is 
also called the Born approximation. The appliance of the excitation moments allowed us to get 
rid of the instrument response (sources and detectors specific characteristics: sources intensity, 
sources delays, detectors efficiencies and detectors delays, which would require cumbersome 
calibration procedures if we wanted to evaluate them). 
Let us consider the signal: 
1 () () ()
mx
sd sd sd St Ut Ut
   where 
1    represents the 
deconvolution operator. We define the intensity 
0 ()
() If f   and the mean time t(f), defined 
as 
10 /
() () f f . From now, we will omit the dependence with the time t to simplify the writing. 
Using the moment’s rules, the contribution of moments of the IRF disappears and we get: 
 
ˆ () ()
() ˆ () ()
mm
sds d
sd x x
sd sd
IU IU
IS
IU IU
   (6) 
  ˆˆ ()() ()() ()
mx mx
sds ds ds d s d tS tU tU tU tU    (7) 
This indicates that these two quantities are the same for the model-predicted data and the 
experimental data, and as a matter of fact, are independent of the IRF. In practical terms, these 
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difference of the fluorescence and excitation mean time. Our main hypothesis was that we 
were searching for a unique fluorescent inclusion. In the case of a fluorescent dot located at 
position  m r

, the models of intensity and mean time of S, respectively Isd,m ant tsd,m,  have 
simple expressions: 
 
(0) (0)
, (0)
ˆ ( ) () . . ()
ˆ () ()
m
sds m m d m
sd m x
sd sd
I UG r F G r
I
Gr IU

 
    (8) 
 
(1) (1) (1)
, (0) (0) (0)
() () () ˆˆ () ()
() () ()
mx s md m s d
sd m sd sd
s md m s d
Gr Gr Gr
tt U t U
Gr Gr Gr
    
 
     (9) 
where 
(0)() mm F Fr 

. In particular, Eq. (9) shows that the mean time of S is independent of 
the fluorescence concentration. 
To find the position of the fluorophore, each position m of the fluorophore was tested. 
Here is a summary of the different steps in our reconstruction method: 
Step 1: Forward model calculation: numerical calculation of the Green functions 

(0)
s m Gr

, 
(0)
dm Gr

,  
(1)
s m Gr

and   
(1)
dm Gr

 for each source-detector couple, and for 
every voxel m. 
Step 2: For every voxel, calculation of the optimal    mm F r

 (Eqs. (10) and (11)) by 
comparing the intensities. 
   
2
1 arg(min( )) mm m Fr  

 (10) 
   
2
2
1
,
ˆ ()()
var( ( ))
sd sd
m
sd sd
IS IS
IS


    (11) 
Step 3: For every voxel, calculation and optimization of a global criterion 
2
2m   taking 
into account both intensities and mean times, with  m F  calculated at step 2: 
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2
2
,,
ˆˆ ( ( ) ( )) ( ( ) ( )) 11
2 var( ( )) 2 var( ( ))
sd sd sd sd
m
sd sd sd sd
IS IS tS tS
IS tS


     (12) 
where the operator var designs a modeled variance of the signal, taking into account the 
photon noise and laser intensity random variations. 
Step 4: A threshold was applied on the criterion to select a localization map. 
Step 5: The localization map was scaled to minimize the criterion in Eq. (11) to quantify 
the fluorescence. 
2.4. Signal preprocessing 
Several steps were required before the measurements could be handled for reconstruction. We 
call a measurement a set of three measures: i) an excitation measurement, ii) a fluorescence 
measurement, iii) a fluorescence measurement without the fluorescent inclusion. The third 
measurement corresponds to a parasite signal featuring leaks from the excitation and 
autofluorescence of the medium and system. This measurement was subtracted to the raw 
fluorescence data [22]. This was possible as we were working on phantom experiments. 
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the first part of the temporal curve before the peak. 
Step 2: For each raw fluorescent signal, the corresponding parasite signal was subtracted. 
Step 3: For intensity calculation, the fluorescent intensity was normalized by the 
excitation intensity. 
Step 4: For mean time calculation, a mask was applied to the data in order to remove the 
effects of the background. The time interval was chosen between 1% of the peak 
value on both edges of the peak. 
2.5. Evaluation of the method 
The reconstruction accuracy was studied by varying the location of the inclusion in the three 
directions under the imaging probe. In the first experiment, the inclusion was placed at 
different depths under the probe (z change). The depth of the inclusion was varied from 6.2 
mm under the probe up to 18.2 mm (center of the inclusion), with a 3 mm step. In the second 
set of experiments, the inclusion was moved perpendicularly to the lines of sources and 
detectors (x change) within a 16 mm range, with a 4 mm step, for a depth of the inclusion of 
9.2 mm under the probe. In the third set of experiments (same depth), the inclusion was 
moved parallel to the lines of sources and detectors (y change) within a 16 mm range, with a 4 
mm step. Accuracy was reported through the difference of the reconstructed values and the 
true value that is called the residual. The median (δmed), the standard deviation (δrms) and the 
maximum absolute deviation (δmax) of the residual were computed to evaluate the 
reconstruction. 
  calculated  true i rv a l u e v a l u e      (13) 
  median( ) med i r      (14) 
 
2
1
1
N
rms i
i
r
N


     (15) 
  max max( ) i r      (16) 
Then we checked the precision of the method by performing ten sequential sets of 
measurements. Finally, the input optical parameters were manually changed in order to study 
the influence of false parameters on the results. The absorption coefficient, the diffusion 
coefficient and the fluorescence lifetime were changed on a 20% range ( ± 10% and ± 20%) 
and the reconstruction was processed for different z locations. We chose these values as ± 
10% corresponds usually to the error made when measuring the optical properties. Thus the ± 
20% range increases that range and also may account for heterogeneity inside the prostate. 
3. Results 
3.1. Varying the inclusion location 
In the first experiment where the depth of the inclusion varied, a very high accuracy was 
obtained on the z location with  () rms z   = 0.06 cm. The results can be represented visually by 
plotting the calculated values and the true values, in the (y,z) plane as in Fig. 3 (a). Figure 3 
(b) shows the linear regression for these values, with a slope close to 1. The model we applied 
assumed a point-like inclusion, which is not the case in practice. With this model, we 
estimated a depth which is close to the center of the inclusion.  max() x   and max() y  were equal 
to 0.24 and 0.16 cm respectively. This may be explained by the experimental errors when we 
centered the inclusion under the probe. 
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Fig. 3. Results of the reconstruction (diamonds) for different true depths of the inclusion under 
the probe (square). The real locations of the inclusion are represented with squares, from 14 to 
26 mm with a 3 mm step. (a) in the (y,z) plane (b) z calculated as a function of z true. 
In the second set of experiments where the inclusion was moved perpendicularly to the 
lines of sources and detectors, the reconstruction gave a very good accuracy, with standard 
deviations of 0.15 cm and 0.07 cm for x and y respectively (Fig. 4). However, the x estimation 
was not as good for positions 0.4 and 0.8 cm as for positions 0.4 and 0.8 cm. Even if these 
positions were supposed to be symmetric, the difference was due to the glass tube holding the 
fluorophore. For positions 0.4 and 0.8 cm, the empty glass tube was centered under the probe 
and thus guided the light toward the negative y. This distorted part of the reconstructed 
location and explains that the regression on Fig. 4 (b) as well as the standard deviation on z are 
not as good as in the previous experiment. 
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Fig. 4. Results of the reconstruction (diamonds) for different lateral positions of the inclusion 
(constant depth). The inclusion was moved perpendicularly to the lines of sources and 
detectors. The real locations of the inclusion are represented with squares, from 0.8 to 0.8 mm 
with a 4 mm step. (a) in the (x,y) plane (b) x calculated as a function of x true. 
In the third set of experiments (inclusion moved parallel to the lines of sources and 
detectors), the y position is well estimated with  () rms y   = 0.11 cm (Fig. 5 (a)). Instead of a 
zero centered position, the x result is slightly shifted on negative values with  () med x   = 0.15 
cm. This is due again to the geometry of the glass tube we used. This was proved with the tube 
placed on the other side (x>0) and the shift followed on the positive values (results not shown 
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(C) 2011 OSA 1 January 2011 / Vol. 2,  No. 1 / BIOMEDICAL OPTICS EXPRESS  202here). The calculated depth has a good accuracy as well ( () rms z   = 0.07 cm) similar to the one 
that was obtained for the first experiment. 
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Fig. 5. Results of the reconstruction (diamonds) for different lateral positions of the inclusion 
(constant depth). The inclusion was moved parallel to the lines of sources and detectors. The 
real locations of the inclusion are represented with squares, from 0.8 to 0.8 mm with a 4 mm 
step. (a) in the (x,y) plane (b) y calculated as a function of y true. 
A summary of all the results is given in Table 1. 
Table 1. The median, the standard deviation and the maximum absolute deviation from 
the residual of the reconstructed values for x, y and z, for the three displacements 
   z variation (cm)     x variation (cm)     y variation (cm) 
  
med   
rms   
max      
med   
rms   
max      
med   
rms   
max   
x  0.15 0.17 0.24      0.15 0.15 0.22      0.06 0.09 0.15 
y  0.16 0.12 0.16      0.01 0.07 0.13      0.07 0.11 0.17 
z  0.02 0.06 0.11      0.11 0.17 0.26      0.12 0.07 0.23 
3.2. Repeatability 
Using the ten sequential sets of measurements, the repeatability standard deviations were 
found to be 0.10, 0.11 and 0.06 cm for x, y and z, respectively. These precision values are of 
the same order of magnitude as the previous accuracy values. 
3.3. Influence of background optical properties determination 
Varying the absorption coefficient in a ± 20% range around the measured value has very little 
influence on the calculated values. The results can be seen on Fig. 6 (a) for the first 
experiment with different depths. The maximum standard deviation was  () rms z   = 0.13 cm for 
a   = 0.24 cm
1. Even if it is remaining small ( max   = 0.18 cm), the impact was maximal for 
the highest depth z = 2.82 cm for which we can clearly observe the z dispersion versus the 
absorption coefficient. By checking the speed’s formula in an infinite medium 
(
' 2( 3 ) as vc    ) for example, we observe that it increases with the absorption coefficient. 
This is in agreement with the plot where the calculated depth increased with the absorption 
coefficient. A larger path is making up for a higher speed. 
In a similar way, the impact on the calculated values was even smaller when the diffusion 
coefficient changes (Fig. 6 (b)). The maximum standard deviation was  () rms z   = 0.13 cm for 
'
s   = 14.4 cm
1 (highest simulated value). For the highest depth (z = 2.82 cm), we notice that 
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Fig. 6. Calculated depth (z) as a function of theoretical depth (a) for different absorption 
coefficients around 
a   = 0.3 cm
1 ± 10% and ± 20% (b) for different diffusion coefficients 
around 
'
s   = 12 cm
1 ± 10% and ± 20%. 
For five lifetimes between 0.44 and 0.66 ns (  = 0.55 ns ± 10% and ± 20%), we 
calculated the corresponding depths for the first experiment. These changes had a few impact 
on the (x,y) location, indeed the standard deviation  rms  remains constant, around 0.15 cm and 
0.11 cm for x and y respectively. As expected, the changes were more important for the z 
location. The results are shown on Fig. 7. The calculated depth decreases as the input lifetime 
increases. As a matter of fact, for a same mean time, the distance has to decrease in order to 
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Fig. 7. Calculated depth (z) as a function of theoretical depth for different lifetime around  = 
0.55 ns ± 10% and ± 20%. 
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value) and was equal to 0.22 and 0.28 cm for  = 0.44 ns ( max   = 0.31 cm) and 0.66 ns ( max   = 
0.5 cm) respectively. 
4. Discussion 
In this paper, we have presented a new device and method for fluorescence tomography of the 
prostate. The optical fibers were integrated in a US probe. The acquisition time was reduced to 
a few minutes, which fits the constraints of the clinical environment. We successfully applied 
our reconstruction method to an optical phantom containing a 3 × 3 × 5 mm fluorescent 
inclusion. The reconstruction method was based on the search for a unique inclusion and 
managed a normalized Born approach. A very good accuracy was obtained both in depth and 
lateral displacement of the inclusion. We put some errors down to the glass tube that hold the 
inclusion. Further studies on very small tumors would require another type of inclusion 
(smaller glass tube or fluorophore embedded in a gel ball or a sponge for instance). However, 
we chose this size (0.045 cc) as it is in agreement and even smaller than the mean size of 
nonpalpable cancers, around 0.1 cc [2]. Besides, we restrained ourselves to a region up to 1.82 
cm under the probe, assuming that the probe is squeezed one cm into the prostate. This is in 
accordance with the fact that most of the clinically important prostate cancers (those that are 
potentially morbid or lethal) are found in the peripheral zone whereas the clinically 
unimportant are found in the transition zone [2]. 
Different hypothesis may be discussed. Firstly, optical properties and fluorophore lifetime 
were assumed to be known. Indeed, prior information on the prostate optical properties may 
help the optical reconstruction. Future work will investigate two different ways to obtain the 
medium’s optical properties. The first one would be based on information from measurements 
at the excitation wavelength. The second one could use information for the US measurement. 
According to the results, even a 20% error on the optical properties measurement implies a 
small error on the inclusion localization ( max   = 0.18 cm). Concerning the fluorescent 
lifetime, we underlined that this parameter is more predominant in the depth resolution. With 
an average speed of light around 4 cm/ns, a 0.1 ns error may induce a 0.2 cm error in the 
inclusion localization. Our choice was to use the value we had measured previously in a 
dedicated measurement. This was justified as the fluorophore did not change its environment 
in our glass tube inclusion. Nevertheless, this will not be the case anymore for an in vivo 
experiment and it is well-known that this parameter is very sensitive to local tissue 
environment [23,24]. Different methods may be explored to overcome this a priori 
knowledge. Keeping the basis of our reconstruction method, a differential method as in 
reference [25] could be adapted. Other groups have also chosen different more elaborate 
[13,26] or simple [27] reconstruction methods in which the lifetime is an additional unknown. 
Another limitation for in vivo measurements is the subtraction of the parasite signal. 
For an actual patient, it can be envisioned to measure this signal before injection of the 
fluorescent marker but one can imagine both patient discomfort and potential calibration 
problems. Another possibility would be to find a spot on the tissue without markers. However, 
we are currently working on a feasible method to establish a model for the parasite signal and 
apply a temporal filter to get rid of this signal. 
Furthermore, we presented an algorithm dedicated to the search of a unique inclusion as a 
first step in our studies. Prostate cancer tends to be multifocal in 50-76% in all cases of radical 
prostatectomy [28], moreover, they tend to be bilateral for small-volume prostate cancers [29]. 
The average number of prostate tumors is between 2 and 3 [28,30]. These facts justify the 
search for a unique tumor in each of the bilateral parts of the prostate. We are currently 
working on algorithms for detection of two tumors to ensure an even better reliability. 
Besides, we did not address the quantification problem for now as we assumed that this was 
not crucial for biopsies guiding. 
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markers are not developed yet for the prostate, very few information is available on the 
expected levels of specificity. Ongoing work is studying the effects of nonspecific 
fluorescence on reconstruction and new methods to overcome this signal. 
5. Conclusion 
A novel device for time-resolved imaging of the prostate was presented. Our original method 
was derived and evaluated. High accuracy was shown on localization of a 45 µL fluorescent 
inclusion of ICG in an optical phantom mimicking the prostate. We obtained accuracy better 
than 0.15 cm in the three directions of space and a precision around 0.1 cm. This is compatible 
with the size of early stage tumors. The ultimate goal of this device is to work simultaneously 
with the US imaging. After phantom validation for systems coregistrations, further 
investigations will be then needed on canine animal model for example to demonstrate the 
benefits provided by an optical diagnosis. 
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